New trial aims to boost survival in kids with rare lymphoma
NCT ID NCT05681260
First seen Mar 22, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study tests which of two chemotherapy methods works better for children newly diagnosed with T-cell lymphoblastic lymphoma, a rare cancer. About 200 children will receive either high-dose methotrexate or a different escalating dose, both combined with standard drugs. The goal is to improve the chance of staying cancer-free and to learn more about how to interpret PET scans and treat those who don't respond early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T CELL LYMPHOBLASTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Children's Medical Center
RECRUITINGShanghai, Shanghai Municipality, 200127, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
West China Second University Hospital
NOT_YET_RECRUITINGChengdu, China
Contact
Conditions
Explore the condition pages connected to this study.